✦ LIBER ✦

Evidence for a direct effect of gonadotrophin releasing hormone agonist in human hormone sensitive prostatic cancer cell lines

✍ Scribed by R Scaletsky; J Waxman; K Sikora; R Clayton

Book ID: 116006688
Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 119 KB
Volume: 28
Category: Article
ISSN: 0022-4731
DOI: 10.1016/0022-4731(87)91359-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pituitary apoplexy of a gonadotroph aden

Pituitary apoplexy of a gonadotroph adenoma following gonadotrophin releasing hormone agonist therapy for prostatic cancer

✍ Reznik, Y.; Chapon, F.; Lahlou, N.; Deboucher, N.; Mahoudeau, J. 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 495 KB

Direct inhibitory effect of a luteinizin

Direct inhibitory effect of a luteinizing hormone-releasing hormone agonist on MCF-7 human breast cancer cells

✍ Blankenstein, M.A.; Henkelman, M.S.; Klijn, J.G.M. 📂 Article 📅 1985 🏛 Elsevier Science ⚖ 801 KB

Direct effects of GnRH agonists in human

Direct effects of GnRH agonists in human hormone-sensitive endometrial cells

✍ G Sica; G Schinzari; C Angelucci; G Lama; F Iacopino 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 310 KB

Effects of Triptorelin, a Gonadotropin-R

Effects of Triptorelin, a Gonadotropin-Releasing Hormone Agonist, on the Human Prostatic Cell Lines PC3 and LNCaP

✍ L. RAVENNA; L. SALVATORI; S. MORRONE; C. LUBRANO; M.R. CARDILLO; F. SCIARRA; L. 📂 Article 📅 2000 🏛 American Society of Andrology 🌐 English ⚖ 118 KB

Knocking down gene expression for growth

Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines

✍ Barabutis, N; Schally, A V 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 250 KB

Growth-inhibitory effects of luteinizing

Growth-inhibitory effects of luteinizing hormone-releasing hormone (LHRH) agonists on xenografts of the DU 145 human androgen-independent prostate cancer cell line in nude mice

✍ Donatella Dondi; Roberta M. Moretti; Marina Montagnani Marelli; Graziella Prates 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 131 KB 👁 2 views

Experiments have been performed to clarify whether LHRH agonists might decrease growth of hormone-unresponsive prostate cancer in vivo. Male nude mice were injected s.c. with the human androgen-independent prostate tumor DU 145 cells; osmotic minipumps releasing the LHRH agonist Zoladex (LHRH-A) for